These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21980493)

  • 21. Cathepsin L, but not cathepsin B, is a potential kininogenase.
    Desmazes C; Gauthier F; Lalmanach G
    Biol Chem; 2001 May; 382(5):811-5. PubMed ID: 11517935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
    Elborn JS; Cordon SM; Shale DJ
    Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
    Ohman DE; Chakrabarty AM
    Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
    Pol E; Björk I
    Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis.
    Delacourt C; Le Bourgeois M; D'Ortho MP; Doit C; Scheinmann P; Navarro J; Harf A; Hartmann DJ; Lafuma C
    Am J Respir Crit Care Med; 1995 Aug; 152(2):765-74. PubMed ID: 7633740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
    Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
    Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
    Hovold G; Lindberg U; Ljungberg JK; Shannon O; Påhlman LI
    Respir Med; 2020; 170():105994. PubMed ID: 32843162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
    Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
    Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review).
    Kos J; Lah TT
    Oncol Rep; 1998; 5(6):1349-61. PubMed ID: 9769367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
    Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients.
    Robinson CV; Elkins MR; Bialkowski KM; Thornton DJ; Kertesz MA
    J Med Microbiol; 2012 Dec; 61(Pt 12):1644-1653. PubMed ID: 22918866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.
    Rinne R; Saukko P; Järvinen M; Lehesjoki AE
    Ann Med; 2002; 34(5):380-5. PubMed ID: 12452481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis.
    Savelev SU; Perry JD; Bourke SJ; Jary H; Taylor R; Fisher AJ; Corris PA; Petrie M; De Soyza A
    Lett Appl Microbiol; 2011 Jun; 52(6):610-3. PubMed ID: 21438899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa.
    Jones AM; Martin L; Bright-Thomas RJ; Dodd ME; McDowell A; Moffitt KL; Elborn JS; Webb AK
    Eur Respir J; 2003 Sep; 22(3):503-6. PubMed ID: 14516142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum.
    Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V
    Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
    Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
    Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L.
    Desmazes C; Galineau L; Gauthier F; Brömme D; Lalmanach G
    Eur J Biochem; 2003 Jan; 270(1):171-8. PubMed ID: 12492488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
    Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
    J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.